IDEXX Laboratories, Inc. IDXX is set to release fourth-quarter 2025 results on Feb.2, before the opening bell. In the last ...
Investor's Business Daily on MSN
IBD stock of the day: Pet-health firm Idexx Laboratories looks to build on 2025 rally
Idexx stock is starting the year strong as Wall Street remains bullish the animal diagnostics company.
IDEXX Laboratories (NASDAQ:IDXX) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...
IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...
A substantial insider activity was disclosed on February 12, as Erickson, Executive Vice President at IDEXX Laboratories (NASDAQ:IDXX), reported the exercise of a large sell of company stock options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results